Common Mechanisms in Autoimmunity Insight Awards
Forecasted
Breakthrough T1D’s Common Mechanisms in Autoimmunity Insight Awards fund research into shared biological mechanisms between type 1 diabetes and other autoimmune diseases to advance T1D prevention and treatment.
Funder: Breakthrough T1D
Due Dates (Anticipated): January 2027 (Full proposal deadline, projected)
Funding Amounts: Up to $3,000,000 total for up to 3 years; actual budget varies by project scope.
Summary: Supports research on shared mechanisms between type 1 diabetes and other autoimmune diseases to advance prevention or treatment strategies for T1D.
Key Information: Letter of Intent (LOI) required before full proposal submission.
Description
This funding opportunity from Breakthrough T1D is designed to support research that investigates biological pathways, processes, or molecular targets common to type 1 diabetes (T1D) and other autoimmune diseases. The program encourages cross-disease comparisons and mechanistic studies that can uncover novel insights into autoimmunity, with the ultimate aim of informing innovative strategies for the prevention or treatment of T1D. Proposals should demonstrate clear relevance to T1D and focus on mechanisms shared with other autoimmune conditions.
